Remission

Though sometimes complex, treat-to-target strategies for psoriatic arthritis can lead to lower symptom states, better physical functionality and less structural damage to joints, according to Philip Mease, MD, a clinical professor at the University of Washington School of Medicine and Director of rheumatology research at the Swedish Medical Center in Seattle.

Oral lyophilized fecal microbiota transplantation following antibiotic use induced and maintained remission in patients with active ulcerative colitis, according to research published in Lancet Gastroenterology and Hepatology.

In a video exclusive, Jan Wehkamp, MD, vice president, gastroenterology global disease area leader at Janssen Pharmaceuticals, reported positive long-term data evaluating Tremfya for the treatment of patients with Crohn’s disease.

Hydroxychloroquine maintenance, compared with reducing or discontinuing, is associated with a lower risk for flare among patients with systemic lupus erythematosus in remission or very low disease activity, according to data presented here.

Approximately half of patients who reduced their disease-modifying antirheumatic drugs while in stable rheumatoid arthritis remission maintained their remission status, according to data published in The Lancet Rheumatology.

LAS VEGAS – Patients dosed with Skyrizi for Crohn’s disease achieved clinical remission, endoscopic response and persistent improvements to inflammatory biomarkers consistent with a dose-response relationship.

Higher ustekinumab trough concentration levels correlated with increased rates of endoscopic remission among patients with Crohn’s disease, according to research published in BMC Gastroenterology.

The assumption that half of childhood ADHD cases remit by adulthood may be inaccurate, as symptoms fluctuate into adulthood in most cases, according to results of a multimodal treatment study published in American Journal of Psychiatry.

Adalimumab was an efficacious and safe treatment option for pediatric patients with moderate to severe ulcerative colitis, according to findings published in Lancet Gastroenteroly and Hepatology.

Tapering conventional synthetic DMARDs to a half-dose was inferior to stable-dose regimens for preventing flares during a 1-year period among patients in rheumatoid arthritis remission, according to data published in JAMA.